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Modelling COVID 19 in the Basque 
Country from introduction 
to control measure response
Maíra Aguiar1,2,3*, Eduardo Millán Ortuondo4, Joseba Bidaurrazaga Van‑Dierdonck5, 
Javier Mar6,7,8 & Nico Stollenwerk1,9
In March 2020, a multidisciplinary task force (so‑called Basque Modelling Task Force, BMTF) was 
created to assist the Basque health managers and Government during the COVID‑19 responses. BMTF 
is a modelling team, working on different approaches, including stochastic processes, statistical 
methods and artificial intelligence. Here we describe the efforts and challenges to develop a flexible 
modeling framework able to describe the dynamics observed for the tested positive cases, including 
the modelling development steps. The results obtained by a new stochastic SHARUCD model 
framework are presented. Our models differentiate mild and asymptomatic from severe infections 
prone to be hospitalized and were able to predict the course of the epidemic, providing important 
projections on the national health system’s necessities during the increased population demand 
on hospital admissions. Short and longer‑term predictions were tested with good results adjusted 
to the available epidemiological data. We have shown that the partial lockdown measures were 
effective and enough to slow down disease transmission in the Basque Country. The growth rate  
was calculated from the model and from the data and the implications for the reproduction ratio r 
are shown. The analysis of the growth rates from the data led to improved model versions describing 
after the exponential phase also the new information obtained during the phase of response to 
the control measures. This framework is now being used to monitor disease transmission while the 
country lockdown was gradually lifted, with insights to specific programs for a general policy of “social 
distancing” and home quarantining.
In December 2019, a new respiratory syndrome called coronavirus disease 2019 (COVID-19) caused by a new 
coronavirus (SARS-CoV-2)1 was identified in  China2 and spread rapidly around the globe. With human-to-
human transmission confirmed in 3 countries outside China, COVID-19 was declared a Public Health Emer-
gency of International Concern by the World Health Organization (WHO) on 30 January 2020. By February 25, 
2020, China was the epicenter of the outbreak and, in 2 weeks, on March 11, 2020, COVID-19 was characterized 
as a pandemic, with Europe reporting more cases and deaths than the rest of the world combined, apart from 
 China3. Up to April 25, 2020, more than 2.8 million cases were confirmed with about 200 thousand deaths, with 
a global case fatality ratio (CFR) of approximate 7%4.
Italy, the first hardest hit country in Europe, had local transmission confirmed in all regions in the beginning 
of March, 2020. Eleven municipalities in northern Italy were identified as the centers of the two main Italian 
clusters. On March 8, 2020, the Prime Minister Giuseppe Conte had placed in quarantine all of Lombardy and 
14 other northern provinces. The national lockdown decree was signed on March 9,  20205, prohibiting all forms 
of gathering of people in public places and suspending sports events and competitions of all types. By that time, 
Italy, was considered the new epicenter of the outbreak, reporting more than 9 thousand confirmed cases with 
more than 450 deaths. On March 21, 2020, further restrictions within the nationwide lockdown were imposed 
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with all non-essential production, industries and businesses halted, as the number of new cases and deaths were 
still rising. In respect to the total number of confirmed cases, Spain was 8 days behind Italy, with cases reported 
in all 50 provinces of the country on March 8, 2020. The decree of a national lockdown was signed on March 14, 
 20206, with all non-essential workers staying at home from March 27, 2020,  onwards7,8.
In the Basque Country, an autonomous community in northern Spain with 2.2 milion inhabitants, the first 
cases of COVID-19 were notified on March 4, 2020. A public health emergency was declared before any other 
region in  Spain9. All schools in the Basque Country were closed by March 12, 2020, and, ruled by the same 
Spanish  decrees6–8, lockdown measures were implemented accordingly and in time. An extension of the state of 
alarm was published on April 10,  202010, and although teleworking is still prioritized, some restrictions started 
to be lifted, with workers in some non-essential sectors allowed to return to work using face masks on April 13, 
2020, and children under the age of 14 allowed to go outside for a walk, within a one-kilometer radius of their 
home, on April 26,  202011. The national plan for lifting the restrictions imposed during the state of alarm called 
“Plan for the Transition towards a new normality” was announced on April 28,  202012, and will take place over 
4 phases with a “gradual, flexible and adaptive” de-escalation to “a new normality”, depending on the on-going 
progress of COVID-19 epidemic’s control across the different regions of Spain. Started on May 4, 2020, with its 
“Phase Zero”, the proposed plan will last eight weeks, until the end of June.
As the COVID-19 pandemic is unfolding, research on mathematical modelling becomes more important 
than ever to understand disease spreading dynamics and the impact of intervention measures. By incorporating 
the new information generated by virology, field epidemiology and social behaviour, for example, mathematical 
models are often used to guide public health authorities with projections for the national health system’s necessi-
ties during an outbreak. Those mathematical models also provide insights about the disease spreading over time, 
assessing the impact of human interventions for disease control, and Governments in some countries have already 
taking important decisions based on these  results13–15. Worldwide country lockdowns are unprecedented extreme 
measures recently taken and, although needed to decelerate disease transmission, have caused a huge economic 
crises around the globe. As some countries on the northern hemisphere start to announce that they were able 
to control the spreading of the disease and have now “reached the peak” of the epidemic, Governments start to 
consider to relax the imposed restrictions, and once again, mathematical models become essential guiding tools 
to evaluate the impact of the ongoing partial lockdowns lifting on disease transmission intensities, for different 
epidemiological scenarios, combined with many other public health measures that must take place for continu-
ing COVID-19 prevention and mitigation such as testing, contact tracing and isolation of infected individuals.
The COVID-19 pandemic has resulted in an avalanche of epidemiological modelling papers, most of them 
using simple models such as the SIR (Susceptible-Infected- Recovered) or SEIR (Susceptible-Exposed-Infected- 
Recovered) in mechanistic or probabilistic frameworks to understand and predict the spread of the disease in 
a population. Modelling the dynamics of COVID-19 is very challenging, as we know very little about disease 
transmission. More complex models would be able to give more accurate projections about specific variables 
such as number of hospitalizations, intensive care units admissions (ICUs) and deaths, for example, over the 
course of the epidemics. However, to build useful models, good quality empirical data and its understanding, 
as well as a close collaboration among mathematical modelers, field and laboratory researchers as well as public 
health stakeholders are  essential16–21.
In March 2020, a multidisciplinary task force (so-called Basque Modelling Task Force, BMTF) was created 
to assist the Basque Health managers and the Basque Government during the COVID-19 responses. BMTF is a 
modelling team, working on different approaches, including stochastic processes, statistical methods and artificial 
intelligence. Members were collaborating taking into consideration all information provided by the public health 
frontline and using different available datasets in respect to the COVID-19 outbreak in the Basque Country. The 
primary objectives were: (i) projections on the national health system’s necessities during the increased popula-
tion demand on hospital admissions while the epidemic was unfolding; (ii) description of the epidemic in terms 
of disease spreading and control and (iii) monitoring the disease transmission when the country’s lockdown 
was gradually lifted. All modelling approaches were complementary and were able to provide coherent results, 
assuring that the decisions made using the modelling results were sound and, in fact, adjusted to the current 
epidemiological data. In addition, modelling results provided useful predictive information to validate outbreak 
control decisions and finally, to assist authorities in the Basque Country.
We use stochastic SHARUCD-type models (susceptible (S), severe cases prone to hospitalization (H), mild, 
sub-clinical or asymptomatic (A), recovered (R), patients admitted to the intensive care units (U) and the 
recorded cumulative positive cases (C) which includes all new positive cases for each class of H, A, U, R, and 
deceased (D))—an extension of the well known simple SIR model that is frequently used to model different 
disease  outbreaks28–30. The deterministic approach is obtained via the mean field approximation of the stochastic 
system and is also used to evaluate the model performance and accuracy to guide the modeling analysis. The 
model is calibrated using the empirical data for the Basque Country community and the biological parameters 
are either estimated or fixed as the model is able to describe the disease incidence data. The growth rate (  ) 
was calculated from the model and from the data and results for the reproduction ratio (r) are shown. As the 
epidemic has entered into its linear phase, with the new number of cases increasing less and stabilizing, we keep 
monitoring, within the BMTF, the effect of the control measures on disease transmission. As this paper is revised, 
it is important to mention that the longer-term predictions of the development of the epidemic in the Basque 
Country turned out to be correct, with the notified cases well within the 95% confidence intervals for the studied 
epidemiological scenario (from introduction toward control).
In this paper we describe our efforts as a task force to develop a flexible modeling framework, able to describe 
the dynamics observed for the tested positive cases, hospitalizations, intensive care units (ICUs) admissions, 
deceased and finally the recovered. Keeping the biological parameters for COVID-19 in the range of the recent 
research  findings22–27, but adjusting to the phenomenological data description, we were able to explain well the 
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exponential phase of the epidemic and later to evaluate the effect of the imposed control measures. While using 
the real time data provided by the Basque Health Managers, from March 4 up to May 4, we were able to refine 
the models as we learned from the epidemic in the Basque Country. As a follow up exercise, while the epidemic 
was unfolding and the control measures were implemented, our results are presented and discussed. These are 
the first publicly available modelling results for the Basque Country and the efforts are continued taking into 
consideration the updated data and new information that are generated over time. Preparation for a possible 
second wave of transmission is also discussed, but not explicitly modeled, as the eventual influence of seasonality 
and the role of acquired immunity are not clear nor well measurable yet.
Methods and results
Epidemiological data and data inspection. Epidemiological data used in this study are provided by 
the Basque Health Department and the Basque Health Service (Osakidetza), continually collected with spe-
cific inclusion and exclusion criteria, and for the present analysis, the last update was on May 4, 2020. This is a 
dynamical work and new results are presented throughout the manuscript as new data are collected to calibrate 
the models. We use the following incidence and cumulative data for RT-PCR (reverse transcriptase-polymer-
ase chain reaction) tested positive patients (yellow), recorded as hospital admissions (red), intensive care units 
admissions (purple), recovered (green) and deceased (black), as shown in Fig. 1. The remaining patients are 
assumed to be individuals with milder infections. Data sets for hospitalizations, ICU admissions, discharges and 
deceases were obtained from the Osakidetza’s Business Intelligence (OBI) platform, enabling us to exploit and 
analyze the empirical data from the main information systems of Basque Health Service, including the struc-
tured data from the electronic health records of the Basque Health Service. In a different format, data is publicly 
available and can be retrieved  from31,32.
At the beginning of the outbreak, RT-PCR tests were only performed to those patients with severe symptoms 
admitted to hospital. From March 22 onwards, testing capacities have increased, with antibody tests introduced 
on April 6, 2020, and used mainly as screening tool in nursing homes, where less severe symptomatic cases started 
to be tested. Data from different sources are linked by a pseudonymous identification of the patient.
Definition of each variable and data flow path withing the BMTF. Positives cases are patients tested positive 
for the first time with a RT-PCR test. Hospitalizations and ICUs refer to tested positive patients admitted to a 
hospital and intensive care unit respectively. A unique episode (hospitalization) is considered in case of patient 
transfer between hospitals in the Basque Country. To avoid including hospitalizations not related to COVID-19 
infection, hospitalizations with a discharge date before the notification of the positive test are excluded and only 
hospitalizations that at a certain moment were in charge of services a priori responsible of attending COVID-19 
disease are included: (internal medicine, pediatrics, ICU or reanimation services, respiratory services and infec-
tion disease services). The recovered variable refers to notified hospital and ICU discharges, excluding death. 
This data set does not include recovered individuals that were tested positive but not admitted to a hospital and 
like that represents only part of the expected recoveries in the population. As postmortem examination is not 
used as a tool of investigation prior to death  notification33, deceased include both hospital and outside hospital 
deaths with positive PCR test.
To validate those variable definitions with the available data, the following path was used: (i) data are extracted 
from OBI and transformed following the above described definitions, (ii) data sets are shared with collaborators 
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Figure 1.  Cumulative COVID-19 cases of tested positive ( Icum ), hospitalized cases ( CH ), ICU admission ( CU ), 
recovered ( CR ) and deceased cases (D). The imposed control measures and its gradual lifting process are marked 
with arrows with the effective dates of implementation.
4
Vol:.(1234567890)
Scientific Reports |        (2020) 10:17306  | https://doi.org/10.1038/s41598-020-74386-1
www.nature.com/scientificreports/
definitions, adjusting if necessary, (iii) data are used to validate mathematical models developed to describe 
COVID-19 dynamics in the Basque Country and results are discussed during regular BMTF meetings with 
regular reports delivered to the Basque Health managers and the Basque Government, (iv) feedback on the 
reports are sent to the researchers working with data with adjustments on models, parameters and data collec-
tion when necessary.
At first data inspection, the dynamics of the cumulative cases together with the effective starting dates for 
different control measures imposed are shown in Fig. 1.
Modelling framework. We use SHARUCD-type models, an extension of the well known simple SIR (sus-
ceptible-infected-recovered) model, with infected class I partitioned into severe infections prone to hospitaliza-
tion (H) and mild, sub-clinical or asymptomatic infections (A). From a typical SIR model with constant popula-
tion size N = S + I + R , infection rate β and recovery rate γ (and an eventual waining immunity rate α , which 
in the case of COVID-19 is not yet relevant as we assume, preliminarily, that infection leads to immunity during 
the time horizon considered up to now) given by
we develop a basic SHAR-model including a severity ratio η for susceptible individuals S developing severe dis-
ease and possibly being hospitalized H. Milder disease with ratio (1− η) , including sub-clinical and eventually 
asymptomatic infections A, is assumed to have different infectivity φ from severe hospitalized disease β . Here, 
the ratio φ could be smaller or larger than 1 compared to the baseline infectivity rate β , leading to an altered 
infectivity rate φ · β for the A class.
The SHAR-type  model34 is presented by the Eq. system 2, where parameters for disease induced death ( µ ) 
and intensive care units admission ( ν ) are indicated, being relevant for severe disease prone to hospitalization 
but not for mild/asymptomatic cases
This model sketch needs to be further refined adjusting the modelling framework to the available COVID-19 
empirical data. For investigation of φ to be around one or even larger due to higher mobility of mild infected or 
asymptomatic see e.g.35.
For severe infections prone to hospitalization, we assume the following dynamics: severe hospitalized indi-
viduals H could either recover, with a recovery rate γ , be admitted to the ICU facilities U, with a rate ν , or even-
tually, before being admitted to the ICU facilities, decease into class D, with a disease induced death rate µ . The 
ICU admitted patients could recover or die. For completeness of the system and to be able to describe the initial 
phase of the epidemic, an import term  ̺should be also included into the force of infection. The import term 
refers to the imported disease cases, either by infected travelers coming from abroad to the Basque Country and 
transmitting the disease before returning to their home country, or to Basque citizens becoming infected while 
abroad and returning to the Basque Country during their infectious period. This factor becomes important when 
the lockdown is completely lifted, allowing international traveling, but turned out not to be important in the 
initial exponential phase of the epidemic. For the present study, we assume ̺  to be much smaller than the other 
additive terms of the force of infection, given the strong observational insecurities on the data collected at the 
beginning of the outbreak, when ̺  would matter most.
As we investigate cumulative data on the infection classes and not prevalence, we also include classes C to 
count cumulatively the new cases for “hospitalized” CH , “asymptomatic” CA , recovered CR and ICU patients CU . 
In this way we can easily include a ratio ξ of under-notification of mild/asymptomatic cases. The deceased cases 
are automatically collecting cumulative cases, since there is no exit transition form the death class D. While H 
and U can describe the empirical data reported for each class, the recovered R, which are also cumulative, count 
all biologically recovered, including the undetected mild/asymptomatic cases. Therefore, the CR class is needed 
to describe the present data which count only the notified asymptomatic in terms of ξA . We have finally the 
SHARUCD-type models, shown by Eq. system 3, where individual transitions are still subject to refinement upon 
information obtained about COVID-19 biological mechanisms and on additional information directly obtained 
from the data. For a basic first SHARUCD model we keep a balance between biologically necessary and relevant 
model classes, and transitions, and a possibly relatively low number of free parameters, able to be estimated with 
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(H + φA)− (γ + µ+ ν)H
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A = (1− η)β
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(H + φA)− γA
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R = γ (H + A) .
5
Vol.:(0123456789)
Scientific Reports |        (2020) 10:17306  | https://doi.org/10.1038/s41598-020-74386-1
www.nature.com/scientificreports/
The deterministic version of the model is given by a differential equation system for all classes, including the 
recording classes of cumulative cases CH , CA , CR and CU as
We consider primarily SHARUCD model versions as stochastic processes in order to compare with the available 
data which are often noisy and to include population fluctuations, since at times we have relatively low numbers 
of infected in the various classes. The stochastic version can be formulated through the master  equation36–38 
in application to  epidemiology39,40 in a generic form using densities of all variables x1 := S/N  , x2 := H/N  , 
x3 := A/N , x4 := R/N , x5 := U/N , x6 := CH/N , x7 := CA/N , x8 := CU/N and x9 := D/N and x10 := CR/N 
hence state vector x := (x1, . . . , x10)tr , giving the dynamics for the probabilities p(x, t) as
with n = 10 different transitions wj(x) , as described by the mechanisms above, and small deviation from state 
x as xj := 1N · rj
40–42. For the basic SHARUCD model we have explicitly the following transitions wj(x) and its 
shifting vectors rj given by
With these wj(x) and rj specified we also can express the mean field ODE system as shown in the supplementary 
material giving as result the Eq. system 3.
Model simulations and data. Considering as starting points the biological aspects of the  disease26,27,43–46, 
the model is calibrated and parametrized using the cumulative empirical COVID-19 incidence data for CH , 
CU and D directly on the respective data sets, and for the positive tested infected Icum , which includes the new 
reported cases in all recorded classes, except the recovered.
Parameters are estimated and fixed as the model is able to describe the disease incidence during the exponen-
tial phase of the outbreak, see Table 1 in the supplementary material. The stochastic realizations of the model are 
calculated via the Gillespie  algorithm39,47,48, which is considered an exact algorithm once the governing equation, 
the master equation, is specified. Figure 2 shows the ensemble of stochastic realizations of the SHARUCD-type 
model and data, starting from March 4, 2020 until April 4, 2020. The period in time where the empirical data 
can no longer be described by the model simulations without control refers to the end of the exponential phase 
of the epidemic where the exponential growth decelerates into a growth close to zero towards a linear phase.
Our model is able to describe the dynamics observed for each dynamical class, including the observed recov-
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)
w1(x) = ηβx1(x2 + φx3 + ̺), r1 = (1,−1, 0, 0, 0,−1, 0, 0, 0, 0)
tr
w2(x) = ξ(1− η)βx1(x2 + φx3 + ̺), r2 = (1, 0,−1, 0, 0, 0,−1, 0, 0, 0)
tr
w3(x) = (1− ξ)(1− η)βx1(x2 + φx3 + ̺), r3 = (1, 0,−1, 0, 0, 0, 0, 0, 0, 0)
tr
w4(x) = γ x2, r4 = (0, 1, 0,−1, 0, 0, 0, 0, 0,−1)
tr
w5(x) = (1− ξ)γ x3, r5 = (0, 0, 1,−1, 0, 0, 0, 0, 0, 0)
tr
w6(x) = γ x5, r6 = (0, 0, 0,−1, 1, 0, 0, 0, 0,−1)
tr
w7(x) = νx2, r7 = (0, 1, 0, 0,−1, 0, 0,−1, 0, 0)
tr
w8(x) = µx2, r8 = (0, 1, 0, 0, 0, 0, 0, 0,−1, 0)
tr
w9(x) = µx5, r9 = (0, 0, 0, 0, 1, 0, 0, 0,−1, 0)
tr
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the data on the recorded recovered was immediately described, following the behavior observed from the other 
classes and without needing to adjust the previously estimated recovery rate γ.
Parameter uncertainties and model limitations. To investigate the parameter insecurities, we calcu-
late numerically likelihood  functions49 for each parameter conditioned on other parameters and the data, with 
distances between simulations and data from all 5 variables, D(t) , Icum(t) , CH (t) , CU (t) and CR(t) , evaluated 
for the exponential phase of the epidemic. The likelihood plots for each individual parameter, recovery rate ( γ ), 
infection rate ( β ), disease induced mortality rate ( µ ), rate of ICU admissions ( ν ) and ratio of hospital admission 
due disease severity ( η ), the difference in infectivity of asymptomatic and hospitalized ( φ ) and the detection ratio 
of mild/asymptomatic infections ( ξ ) are shown in Fig. 3. Good agreement of the local maxima of the likelihood 
functions are obtained. The basic epidemiological parameters are shown in Fig. 3a–d and the more internal ones, 
concerning the differences between mild and severe disease, are shown in Fig. 3e–g.
Although the parameter set used to describe the exponential phase of COVID-19 outbreak in the Basque 
Country are coinciding well with the calculated maximum likelihood values (see Table 1 in the supplementary 
material), parameters are prone to correlations, often only determined as combinations but not individually 







































































































































































































































































Figure 2.  Ensemble of stochastic realizations of the SHARUCD-type model.The mean field solution is shown 
in light blue. Empirical data are plotted as black/red dots. (a) Cumulative tested positive cases Icum(t) (yellow 
lines), (b) cumulative hospitalized cases CH (t) (red lines), (c) cumulative ICU admission CU (t) (purple lines), 
(d) cumulative deceased cases D(t) (black lines), and (e) cumulative recorded recovered CR(t) (green lines). (f) 
Semi-logarithmic plot of the data and the mean field curves of all variables. For quite some time all mean field 
curves and the data are in parallel, and we could calculate the slope from the model parameters as growth rate  , 
see light blue line.
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material). Models output are based on the data available, which are often incomplete, and for non-existing data 
such as data referring to the proportion of undetected asymptomatic infected as well as how infective those indi-
viduals are (i.e. their contribution to the force of infection as compared to the symptomatic detected individuals) 
during the exponential phase of the epidemic are estimated but not yet validated with empirical data. However, 
these data would eventually change the dynamical behavior obtained for the positive cases and recovered and for 
the other variables it would remain the same. As part of the BTMF initiative, we keep calibrating the model frame-
work with real time updated data. Results are updated and publicly available on the “SHARUCD dashboard”50, 
with the selected parameter set continually used also during the control phase without need of adjustments.
Modelling the effects of the control measures. With the initial parameters estimated and fixed on the 
exponential phase of the epidemic, we model the effect of the disease control measures introduced using a stand-
ard sigmoid function σ(x) = 1/(1+ ex) , shown along the main results presented in “Momentary growth rates 
and momentary reproduction ratio” section, which is able to describe well the gradual slowing down of the epi-
demic, as it turned out later in the response of the disease curves to the control measures, see “Momentary growth 
rates and momentary reproduction ratio section, and its detailed description below. Specifically, the infection 
rate β becomes time-dependent with β(t) = β0σ−(x(t))+ β1σ+(x(t)) , where σ− := 1/(1+ ex) is a downward 
sigmoidal and σ+ := 1/(1+ e−x) is an upward sigmoidal. The time-depend argument is x(t) := a(t − tc) , with 
a = 0.38 d−1 and tc = 26 days after the initial time t0 . Modifications of the lower value of infectivity β1 might be 
needed when the relaxation of the control measures can change the contact probabilities again or in the eventual 












































































































Mild/asymptomatic detection ratio ξ 
Figure 3.  Numerical likelihood functions for the parameters (a) recovery rate γ , (b) infection rate β , (c) 
diseased induced mortality rate µ and (d) rate of ICU facilities admission ν , and (e) hospital admission ratio η , 
(f) infectivity of mild/asymptomatic relative to the hospitalized φ and (g) recording rate of mild/asymptomatic 
cases ξ . Parameter values are presented in Table 1 (supplementary material).
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The prediction exercises shown in the following sections refers to the original modelling framework presented 
in “Modelling framework” section.
Short‑term prediction exercise with control measure. Short-term predictions considering the effective control 
measures described above are shown in Fig. 4. For this exercise, empirical data (black/red dots) were available 
up to April 13, 2020, and model simulations are obtained for seven days longer run than the available data. A 
week later, new data were included to check the quality of the short prediction exercise (see Fig. 4, green/dark 
green squares following the black/red dots). The mean field solution without the control function is plotted in 
light blue, indicating the differences of model prediction with and without control measures. In good agree-
ment, hospitalization and deceased cases are well matched within 50 stochastic simulations obtained with the 
Gillespie algorithm, with data lying in the median range of stochastic realizations. Note that for the likelihood 
functions we use several hundreds of stochastic realizations. The ICU admission data look atypical and can not 
be described with the current control scenario, after the exponential phase of the epidemic. This aspect is inves-
tigated in more detail in the following sections, using further measures and model refinements.
The cumulative incidences for tested positive cases ( Icum ) follow the higher realizations range whereas the 

































































































































































































































































































































































Figure 4.  Ensemble of stochastic realizations of the SHARUCD-model with control and data matching, 
starting from March 4, 2020. The mean field solution without control is shown in light blue. Empirical data 
from March 4 to April 13, 2020 are plotted as black/red dots. Empirical data from April 14 to April 21, 2020 are 
plotted a green squares. For short-term predictions. (a) Cumulative tested positive cases Icum(t) (yellow lines), 
(b) cumulative hospitalized cases CU (t) (red lines), (c) cumulative ICU admission CU (t) (purple lines), (d) 
cumulative deceases cases D(t) (black lines), and (e) cumulative recovered CR(t) (green lines).
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hospitalized because of COVID-19, but not including the recovered individuals which were eventually tested 
positive but did not need hospitalization, follow the lower realizations range. While the deviation observed for 
the total tested positive ( Icum ) can be explained by the increased testing capacities over time since March 22, 2020, 
where more cases are expected to be detected, including sub-clinical infections and eventually asymptomatic 
individuals, the deviation observed for the “recovered” individuals are as expected, since the dynamical vari-
able CR counts, besides the notified H + U  alive discharges, a proportion of tested positive mild/asymptomatic 
individuals that did not need hospitalization ( ξA).
Long‑term prediction with control measures. Longer-term predictions for hospital admission and deceased 
cases are obtained in Fig. 5, with very small numbers of new hospital admission cases (close to zero increment) 
around 130 days after March 4, 2020. Deceased cases are predicted to reach zero increment 2-3 weeks later, due 
to the delay between the onset of symptoms, hospitalization and death. Data used in this prediction exercise were 
available until April 20, 2020 and were not discriminated by diagnostic method (PCR or rapid tests). Therefore, 
the final numbers might contain some overlap and possible double notification occurring since March 22, when 
testing capacity gradually stated to increase, including rapid tests, introduced on April 6, 2020, used as screening 
tool in the Basque Country.
We plot the data continuation with the same criteria as described above, up to May 9, 2020 (green squares), 
to show that the predictions were well within the 95% confidence intervals of the stochastic realizations. It is 
important to mention that data collection criteria were updated on May 10, 2020, to include cases with positive 
PCR only. The parameter set presented here would rather overestimate the number of “confirmed cases by PCR 
only” as a significant difference is observed in all variables, with a 6% and 3% decrease in hospitalizations and 
deceased respectively. To describe these updated data set, a model re-parametrization, which is outside the aim 
of this article, would be needed.
It is important to mention that data collection criteria were updated on May 10, 2020, to include cases with 
positive PCR only. The current parameter set would rather overestimate the number of “confirmed cases by 
PCR only”as a significant difference is observed in all variables, with a 6% and 3% decrease in hospitalizations 
and deceased respectively. To describe these updated data set, a model re-parametrization would be needed.
Growth rate and reproduction ratio. After an introductory phase, the epidemic entered into an expo-
nential growth phase, which started in the Basque Country around March 10, 2020, and due to the effects of the 
imposed control measures has left the exponential growth phase to a slower growth around March 27, 2020, see 
Fig. 2.
The exponential growth phase is typical for any outbreak with disease spreading in a completely susceptible 
population, as observed already in the SIR-system, Eq. (1), with dIdt =
(
β SN − γ
)
· I =:  · I for S ≈ N and hence 
 = ddt ln(I) . For the present SHARUCD model we obtain similarly an exponential growth factor analytically. 
From the active disease classes H and A with the dynamics given by




· tr2 − det  w i t h  t h e  p a r a m e t e r  d e p e n d e n t  t r a c e 
tr = (η + φ(1− η)) · β − (2γ + µ+ ν)  a n d  d e t e r m i n a n t 
det = γ (γ + µ+ ν)− ((γ + µ+ ν)φ(1− η)+ γ η) · β . The dominating growth factor is then given by the 
largest eigenvalue 1 . The concept of the growth rate can be extended into the phase when effects of the control 




















































































































































































Figure 5.  Ensemble of stochastic realizations of the SHARUCD-model. The mean field solution without 
control is shown in light blue. Empirical data, from March 4 to April 20, 2020 are plotted as black/red dots. 
Empirical data, from April 21 to May 9, 2020 are plotted as green dots. For long term predictions, (a) cumulative 
hospitalized cases CH (t) (red lines, up to July 12, 2020) and (b) cumulative deceases cases D(t) (black lines, up to 
August 1, 2020). The scale used here is 1:2 for hospitalizations and deceased cases.
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Another measure of the spreading of the disease in its initial phase is the basic reproduction number ( R0 ), 
the number of secondary cases Is from a primary case Ip during its infectivness before recovering in a completely 
susceptible population, giving in the SIR dynamics reproduction ratio r = β/γ.




· β as the reproduction ratio in a completely susceptible population. This concept can be 
also extended to larger compartmental models and into the phase when effects of the control measures become 
visible and parameters slowly change. The momentary reproduction ratios r can be analyzed, as frequently done 
for the COVID-19 epidemics, but often called “R”. While the momentary growth rate follows directly from the 
time continuous data at hand, the momentary reproduction ratio depends on the notion of a generation time 
γ−1 . The momentary growth rates and momentary reproduction ratio are analyzed below.
Momentary growth rates and momentary reproduction ratio. We calculate the growth rates and reproduction 
numbers for the Basque Country from the COVID-19 data at hand available, from March 4 to May 4, 2020. 
As the absolute value of r(t) is bound to many internal assumptions, recovery period, smoothing and approxi-
mations, which are not valid for time-dependent parameters, the threshold behavior is independent of those 
uncertainties and clearly indicates that the outbreak gets under control from April onwards, allowing a gradual 
lockdown lifting restrictions under constant monitoring. Note that this analysis has terminated on May 4, 2020, 
before the lockdown started to be lifted in the Basque Country.
To obtain the momentary growth rates from data directly we use  = ddt ln(I) at first applied to the cumulative 
tested positive cases Icum(t) obtaining, via a smoothing window, the new cases after time τ as
and hence, the growth rate
From the growth rate, the reproduction ratio is calculated with the recovery period γ−151 obtained from under-
lying models and recent literature about SARS-CoV-2 interaction with human  hosts26,27,43–46. The results are 
given as data dots in Fig. 6a for the growth rates and in Fig. 6b for the reproduction ratios and the black curves 
from the control response β(t) with its sigmoidal shape (black line) using the SHARUCD-model expressions 1 
in Fig. 6a and r1 in Fig. 6b. After an original introductory phase of the epidemic where insecurities in the data 
collection (due to small numbers) were still present while setting up the recording system, the curves agree well, 
from around March 14, 2020 on, with surprisingly good results, also in the lower value of the sigmoidal curve.
The concept of growth rates can be extended to the other measured variables, hospitalizations, deceased 
cases, recovered cases and ICU admitted cases, see Fig. 7. The sigmoidal shape of decreasing growth rates is well 
visible in the hospitalized and the tested positive infected, whereas the deceased and the recovered are following 
only later, and a much slower sigmoidal curve or near to linear decline. Notably, the ICU admitted cases follow 
the sharp sigmoidal decline of growth rate of hospitalized and tested positive cases rather than the growth rate 
of deceased and the recovered.
Analysis of the momentary reproduction ratio and momentary growth  rates51 have shown two groups of 
growth behaviour in response to the lockdown measures. Synchronization of the ICU admission cases with the 
cumulative tested positive cases and hospitalizations was observed, following the sigmoidal function behaviour, 
and the deceased and recovered cases showing a delay in response to the control measures of 8 to 10 days. These 
results led to information about how to refine the model in order to capture the dynamics of the ICU admissions 
better than in the present model as we will describe in the next subsection.
Model refinement based on observations from growth rates of the different data sets. Given 
the observed synchronization of the ICU admission cases with the cumulative tested positive cases and hospi-
talizations, the SHARUCD model is now refined, using data available from March 4 to May 4, 2020.























































































































Figure 6.  (a) Growth rate estimation from the data on positive tested infected cases, and (b) reproduction ratio 
from the same data. With t = 5 days and τ = 7 days, the sigmoidal black curve represents the values of 1 and 
r1 computed on the basis of β(t).
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While in the original model “severity of disease was decided” upon infection with a proportion of infected 
individuals η becoming severely ill prone to hospitalization, the transition into ICU admissions is now changed to 
a ratio, with infection causing from asymptomatic up to very severe cases, with the assumption that ICU admis-
sions are results of infection like as asymptomatic or hospitalization and not progression from hospitalization.
The updated transitions are changed from the previously used form
into
with the parameter ν adjusted from the ICU-admission rate in units of d−1 into an ICU-admission ratio ν ∈ [0, 1] . 
By changing and fixing ν = 0.1 , we obtained immediately a very good agreement between the available cumula-
tive ICU data and model simulations, with only small deviations in the other variables, see Fig. 8c.
In good agreement, the refined model can describe well the hospitalizations (see Fig. 8b), the ICU admissions 
and the deceased cases (see Fig. 8d), well matched within the median of the 100 stochastic realizations from the 
model. The cumulative incidences for tested positive cases (RT-PCR+ only) still follow the higher realizations 
range (see Fig. 8a), due to the increasing testing capacities since March 22, 2020, followed by the introduction of 
rapid tests, on April 6, 2020, as screening tool that the current model (without testing feedback) can not describe 
quantitatively. The cumulative incidences for alive hospital discharges (black dots), used as a proxy for notified 
recovered individuals needing hospitalization because of COVID-19 only, keeps following the lower realizations 
range, when model simulations are obtained for the cumulative notified recovered ( H + U + ξA ), shown in 
Fig. 8e. Orange dots refers to all notified recovered ( H + U + χA ), including also tested positive mild/asympto-
matic infections detected when the testing capacity increased. To describe this new data set, a new transition is 
needed to record the proportion of recovered from detected mild/asymptomatic infections ( χ ). Figure 8f shows 
model simulations obtained for the cumulative notified recovered from hospital ( H + U  ) only. Similarly, in 
order to describe quantitatively this specific available data set, a new transition is needed to record a proportion 
of recovered individuals tested positive without being admitted to the hospital ( ξA).
The calculations of the growth factors and reproduction ratios were updated to the new model modifications, 
namely from the disease class dynamics now as




· tr2 − det  with tr = (η(1− ν)+ φ(1− η)) · β − (2γ + µ) and 




· β . From Fig. 9 we observe the data to follow the exponential growth phase of COVID-
19 epidemic in the Basque Country from about March 14 to March 27, 2020, sensing the slow down due to the 
control measures from March 28, 2020 onwards. Figure 9b shows the semi-logarithmic plot for the refined model 
and its adjusted parameter set matching with the data for all variables. The analytically calculated growth rate 1 
(light blue line) is also shown, close to the mean field solutions (parallel straight lines) for the exponential phase 
of the outbreak.
Prediction up to May 25th. Medium-term prediction exercise under constant external conditions was per-
formed using the last data point available on May 4, 2020. Taking the minimum and the maximum ranges of 
the stochastic realizations as reference, the number of new hospitalizations, shown in Fig. 10a, is predicted to be 
(8)
w1(x) = ηβx1(x2 + φx3 + ̺), r1 = (1,−1, 0, 0, 0,−1, 0, 0, 0, 0)
tr
w7(x) = νx2, r7 = (0, 1, 0, 0,−1, 0, 0,−1, 0, 0)
tr
(9)
w1(x) = η(1− ν)βx1(x2 + φx3 + ̺), r1 = (1,−1, 0, 0, 0,−1, 0, 0, 0, 0)
tr
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Figure 7.  Growth rate estimation for various variables. (a) Growth rate for tested positive cases (yellow), 
hospitalizations (red) and ICU (purple). (b) Growth rate for recovered (green) and deceased (black). Two 
groups of growth behaviour in response to the lockdown measures are observed,’crossing the threshold of zero 
growth at different times.
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Figure 8.  Ensemble of stochastic realizations of the refined SHARUCD-model and data matching. The mean 
field solution without control is shown in light blue. Empirical data are plotted as black/red dots. (a) Cumulative 
tested positive cases Icum(t) , (b) cumulative hospitalized cases CU (t) , (c) cumulative ICU admissions CU (t) , (d) 







































































































































































































Figure 9.  Adjusted SHARUCD model to synchronize ICU admissions with tested positive cases and 
hospitalizations. (a) Data and mean field solutions in natural scale. (b) Data and mean field solutions in semi-log 
scale with adjusted mean field curves and growth rate  as light blue line.
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between ≈ 5600 to ≈ 5750 cumulative cases up to May 25, 2020 and ICU admissions, shown in Fig. 10b, between 
≈ 560 to ≈ 590 cumulative cases up to May 25, 2020. The number of deceased cases, shown in Fig. 10c, is pre-
dicted to be between ≈ 1500 to ≈ 1600 by May 25th, referring to the number of predicted confirmed severe cases 
from 2-3 weeks before (May 5th), due to the delay between the onset of symptoms, hospitalization and death. 
Note that the data used for these predictions did not differentiate the method used for disease cases notification, 
with possible double notification occurring when the rapid tests were introduced as screening tool.
As described in “Long-term prediction with control measures” section, we recall that data collection criteria 
were updated on May 10, 2020 (after this manuscript was submitted), to include cases with positive PCR only. 
The current parameter set would rather overestimate the number of “confirmed cases by PCR only”as a significant 
difference is observed in all variables, with a 6% and 3% decrease in hospitalizations and deceased respectively. 
To describe these updated data set, a model re-parametrization would be needed.
Discussion and future work
In March 2020, a multidisciplinary task force (so-called Basque Modelling Task Force, BMTF) was created to 
assist the Basque Health managers and the Basque Government during the COVID-19 responses. In this manu-
script, we presented the BMTF efforts while developing a flexible modeling framework, allowing refinements 
as new data and knowledge becomes available. As a follow up exercise, we describe the steps considered from 
March 4 up to May 4, while the epidemic was unfolding and the control measures were implemented.
We have analyzed the results obtained with a stochastic SHARUCD-type model framework, taking into 










































































































Figure 10.  (a) Cumulative hospitalized cases CH (t) (red lines), (b) cumulative ICU admissions CU (t) (purple 
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COVID-19 in the range of the recent research findings, but adjusting to the phenomenological data description. 
Using the data provided by the Basque Health Service, models were able to describe the disease incidence data 
with a single parameter set.
A careful data inspection has shown the end of the exponential phase of the epidemic to be around March 26, 
2020, allowing us to infer that the partial lockdown was effective and enough to decrease disease transmission in 
the Basque Country. Disease control was modeled, given the current epidemiological scenario, able to describe 
well the gradual slowing down of the COVID-19 outbreak. Short-term prediction exercises were performed, with 
seven days longer simulation runs than the available data, where hospitalizations, recovered and deceased cases 
matched well within the median of the stochastic model simulations. The ICU admission data looked atypical 
under the baseline proposed model and could only be described qualitatively during the exponential phase of 
the outbreak, however not well quantified afterwards. The cumulative incidence for all positive cases followed 
the higher stochastic realizations range instead and the deviation observed between model simulations and data 
was interpreted by the increased testing capacities with not only the expected increment in the number of new 
positive cases, including sub-clinical infections and eventually asymptomatic individuals, but also with some 
overlap and possible double notification occurring when the rapid tests were introduced as screening tool in 
nursing homes and for the frontline public health workers.
Growth rates ( (t) ) and the reproduction ratio (r) were calculated from the model and from the data and 
the momentary reproduction ratio r was estimated to be below the threshold behavior of r = 1 . Although, by 
May 4, 2020, the number of new cases reported in the Basque Country were decelerating, the outbreak was still 
in its linear growth phase and careful monitoring of the development of the dynamics of the new cases from all 
variables and respectively all data sets is required. The growth rates for various variables are negative, confirming 
the momentary decrease in disease transmission. Moreover, we observed that the dynamics of the hospitaliza-
tions and ICU admissions were synchronized with the total tested positive cases, becoming negative on April 
1, 2020, whereas recovered and deceased cases only follow later, reaching negative growth rate on April 7 and 
April 11, 2020, respectively. These results led to a model refinement to synchronize ICU admissions to hospi-
talizations and to positive tested infected, rather than to deceased and to recovered. The refined model is now 
able to describe well the 5 variables, with the empirical data lying in the median range of stochastic realizations 
using a single parameter set.
The value of the momentary reproduction number is affected by a large number of different factors, many of 
which are difficult to accurately estimate from data. Therefore, particular caution should be used when interpret-
ing momentary reproduction numbers alone for the purposes of policy decisions. The BMTF is monitoring the 
development of the COVID-19 epidemic in the Basque Country by also evaluating the momentary growth rates 
(t) for the positive cases Icum(t) , but also the (t) for hospitalizations ( CH ), ICU admissions ( CU ), deceased (D) 
and recovered cases ( CR ). Without interfering in any political decision, we assist the Basque Health Managers 
and the Basque Government with results that are obtained by this model framework, based on available data 
and evidence as scientific advice.
A mid-term prediction exercise using the refined framework was shown , under constant external conditions, 
with a note of wide confidence intervals considering the higher ranges of model realizations. Models limitations 
and the implication of using different available data sets were discussed.
As future work, a slight adjustment of the model could further improve the description of the tested positive 
cases dynamics and the recovered via testing feedback. This will become more important in the future course of 
the epidemic and will give us better information on the level of asymptomatic and mild infections, allowing to 
infer on population immunity development in the course of the year and eventually the following years.
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